InsiderTrades.com logo
[Urgent] Starlink Set For The Largest IPO In History?
From Paradigm Press   |   Ad
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.
Click here now for the urgent details on this hidden play.

GBS Insider Trading

Insider Ownership Percentage: 0.27%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

GBS Insider Trading History Chart

This chart shows the insider buying and selling history at GBS by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

GBS Share Price & Price History

Current Price: $1.48
Price Change: ▼ Price Decrease of -0.04 (-2.63%)
As of 11/15/2024 01:00 AM ET

This chart shows the closing price history over time for GBS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin

GBS Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/22/2022Spiro Kevin SakirisCFOBuy5,000$0.65$3,250.0050,228View SEC Filing Icon  
6/17/2022Spiro Kevin SakirisInsiderBuy15,970$0.61$9,741.7045,228View SEC Filing Icon  
2/16/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.63$63,000.00View SEC Filing Icon  
2/14/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.70$70,000.00View SEC Filing Icon  
2/10/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.84$84,000.00View SEC Filing Icon  
2/8/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.89$89,000.00View SEC Filing Icon  
2/2/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.92$92,000.00View SEC Filing Icon  
1/31/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.90$90,000.00View SEC Filing Icon  
1/28/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.92$92,000.00View SEC Filing Icon  
12/17/2021Science Biosensor Diagnos LifeMajor ShareholderSell200,000$1.49$298,000.00View SEC Filing Icon  
12/16/2021Tom ParmakellisDirectorBuy2,800$1.69$4,732.00View SEC Filing Icon  
12/6/2021Spiro Kevin SakirisInsiderBuy10,000$1.70$17,000.00View SEC Filing Icon  
11/29/2021Science Biosensor Diagnos LifeMajor ShareholderSell100,000$1.69$169,000.00View SEC Filing Icon  
11/24/2021Science Biosensor Diagnos LifeMajor ShareholderSell100,000$1.64$164,000.00View SEC Filing Icon  
See Full Table
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.

SEC Filings (Institutional Ownership Changes) for GBS (NYSE:GBS)

2.79% of GBS stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GBS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

GBS Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/9/2021BlackRock Inc.21,812$55K0.0%+4,119.0%0.147%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC24,897$98K0.0%N/A0.201%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC118,000$0.47M0.0%+555.6%0.953%Search for SEC Filing on Google Icon
8/13/2021Anson Funds Management LP571,401$2.25M0.2%N/A4.615%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC10,938$43K0.0%N/A0.088%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.18,854$74K0.0%N/A0.152%Search for SEC Filing on Google Icon
8/6/2021WealthShield Partners LLC49,147$0.19M0.0%N/A0.397%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC27,939$0.16M0.0%N/A0.226%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC27,939$0.16M0.0%N/A0.235%Search for SEC Filing on Google Icon
2/17/2021Jane Street Group LLC16,182$0.12M0.0%N/A0.137%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
GBS logo
GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Read More on GBS

Today's Range

Now: $1.48
Low: $1.45
High: $1.52

50 Day Range

MA: $1.61
Low: $0.47
High: $2.24

52 Week Range

Now: $1.48
Low: $0.36
High: $2.89

Volume

95,812 shs

Average Volume

955,325 shs

Market Capitalization

$22.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.